AM
Aravind Manappa Badiger
About Aravind Manappa Badiger
Data last updated:
Aravind Manappa Badiger is a Director at Bdr Pharmaceuticals International Private Limited (since 2012), Director at Magnum Chemi-Gran Private Limited (since 2014) and Director at Spinos Life Science And Research Private Limited (since 2023). The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹1,185 Cr; the largest is Bdr Pharmaceuticals International Private Limited at ₹1,137 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bdr Pharmaceuticals International Private Limited U24230MH2002PTC137329 | Director | 15 Dec 2012 | 2002 | ₹1,137 Cr (FY 2025) | Active |
 Magnum Chemi-Gran Private Limited U24230TG2005PTC046533 | Director | 12 Aug 2014 | 2005 | ₹29.74 Cr (FY 2025) | Active |
 Spinos Life Science And Research Private Limited U85200TZ2016PTC027449 | Director | 18 Dec 2023 | 2016 | ₹17.94 Cr (FY 2025) | Active |
Board colleagues of Aravind Manappa Badiger
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aravind Manappa Badiger
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aravind Manappa Badiger
Aravind Manappa Badiger currently holds 3 directorships: Bdr Pharmaceuticals International Private Limited (Director, since 15 Dec 2012, revenue ₹1,137 Cr (FY 2025)); Magnum Chemi-Gran Private Limited (Director, since 12 Aug 2014, revenue ₹29.74 Cr (FY 2025)); Spinos Life Science And Research Private Limited (Director, since 18 Dec 2023, revenue ₹17.94 Cr (FY 2025)).
Aravind Manappa Badiger was first appointed on 15 Dec 2012 as Director at Bdr Pharmaceuticals International Private Limited. The most recent appointment on record is 18 Dec 2023 at Spinos Life Science And Research Private Limited.
The 3 current companies of Aravind Manappa Badiger that report revenue have a combined latest revenue of ₹1,185 Cr: Bdr Pharmaceuticals International Private Limited ₹1,137 Cr (FY 2025); Magnum Chemi-Gran Private Limited ₹29.74 Cr (FY 2025); Spinos Life Science And Research Private Limited ₹17.94 Cr (FY 2025).
The current boards of Aravind Manappa Badiger's companies include Anand Kailash Bagaria (Bdr Pharmaceuticals International Private Limited), Dharmesh Mahendra Shah (Bdr Pharmaceuticals International Private Limited), Jayesh Shantilal Trivedi (Bdr Pharmaceuticals International Private Limited), Manish Gaur (Bdr Pharmaceuticals International Private Limited), Nilam Maulik Vyas (Bdr Pharmaceuticals International Private Limited), Raheel Dharmesh Shah (Bdr Pharmaceuticals International Private Limited), among others.